/ASNB
ASNB Stock - EKIMAS Corporation
Financial Services|Shell CompaniesOTC
$0.85+6.58%
+$0.05 (+6.58%) • May 16
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.94
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ASNB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.84 – $0.86
TARGET (TP)$0.98
STOP LOSS$0.78
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.58
52W High$1.70
52W Low$0.55
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $5,000 | N/A | N/A | N/A | $2.70M |
| Gross Profit | N/A | N/A | N/A | N/A | $1.98M |
| Gross Margin | 0.0% | N/A | N/A | N/A | 73.4% |
| Operating Income | $-2,919,365 | $-8,472,598,000 | $-309,000 | $-326,000 | $388,000 |
| Net Income | $-2,901,321 | $-8,464,925,000 | $-265,000 | $-326,000 | $-408,000 |
| Net Margin | -58026.4% | N/A | N/A | N/A | -15.1% |
| EPS | $-0.32 | $-1425.35 | $-0.28 | $-0.58 | $-0.86 |
Company Overview
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Loading analyst ratings...
Earnings History & Surprises
ASNBBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2023
EPS Surprise History
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Dec 31, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-1.43 | — | — |
Q1 2023 | Feb 14, 2023 | — | $-0.15 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.89 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.07 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.26 | — | — |
Q3 2021 | Sep 13, 2021 | — | $-0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.18 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.09 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.12 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.18 | — | — |
Q2 2020 | Apr 1, 2020 | — | $-0.32 | — | — |
Q1 2020 | Mar 31, 2020 | — | $0.08 | — | — |
Q4 2019 | Nov 13, 2019 | — | $-0.25 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.02 | — | — |
Q1 2019 | Mar 31, 2019 | — | $0.26 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ASNB
What is ASNB's current stock price?
EKIMAS Corporation (ASNB) is currently trading at $0.85 per share. The stock has moved +6.58% today.
What is the analyst price target for ASNB?
No analyst price targets are currently available for this stock.
What sector is EKIMAS Corporation in?
EKIMAS Corporation operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.
What is ASNB's market cap?
EKIMAS Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does ASNB pay dividends?
No, EKIMAS Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorCDBT
China Dasheng Biotechnology Company
$0.10
Mkt Cap: $0.0B
EATBF
Eat & Beyond Global Holdings Inc.
$0.08
Mkt Cap: $0.0B
ENGA
Engage Mobility, Inc.
$0.16
Mkt Cap: $0.0B
EZRG
EZRaider Co.
$1.00
Mkt Cap: $0.0B
FDOC
Fuel Doctor Holdings, Inc.
$0.27
Mkt Cap: $0.0B
GDVM
Global Developments, Inc.
$0.01
Mkt Cap: $0.0B
HLCO
The Healing Company Inc.
$0.00
Mkt Cap: $0.0B
MTRI
Metro Inc.
$0.01
Mkt Cap: $0.0B
PGID
Peregrine Industries, Inc.
$0.00
Mkt Cap: $0.0B
TOGI
TurnOnGreen, Inc
$0.05
Mkt Cap: $0.0B
Explore stocks similar to ASNB for comparison